• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Tertiary amines

Introduction to 2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethan-1-ol (CAS No. 124438-51-3)

2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethan-1-ol, also known by its CAS registry number 124438-51-3, is a compound of significant interest in the fields of organic chemistry and pharmacology. This molecule is characterized by its unique structure, which combines a piperidine ring with a pyridazine moiety and an ethanol group. The compound's structure has been extensively studied, and its potential applications in drug development have been explored in recent research.

The synthesis of 2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethan-1-ol involves a series of well-defined chemical reactions, including nucleophilic substitutions and reductions. Researchers have optimized the synthetic pathway to achieve high yields and purity, making it suitable for large-scale production. The compound's physical properties, such as its melting point, boiling point, and solubility, have been determined through advanced analytical techniques like NMR and HPLC.

Recent studies have highlighted the potential of this compound as a precursor in the synthesis of bioactive molecules. For instance, its ability to act as a chiral auxiliary in asymmetric synthesis has been reported in several scientific journals. Additionally, the compound has shown promise in medicinal chemistry as a building block for developing novel therapeutic agents targeting various diseases.

The pharmacological properties of 2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethan-1 ol have been investigated in preclinical models. Research indicates that the compound exhibits moderate activity against certain enzymes and receptors, suggesting its potential role in drug design. Furthermore, its safety profile has been evaluated through acute toxicity studies, which demonstrate that it is well-tolerated at therapeutic doses.

In terms of applications, this compound is widely used in academic research for exploring new synthetic methodologies and for studying the structure-property relationships of related molecules. Its versatility as a starting material makes it valuable in both industrial and academic settings.

The latest advancements in computational chemistry have enabled researchers to predict the compound's behavior in various chemical environments. Quantum mechanical calculations have provided insights into its electronic structure and reactivity, aiding in the design of more efficient synthetic routes and potential drug candidates.

In conclusion, 2-[1-(6-methylpyridazin -3 yl)piperidin -4 yl]ethan -1 ol (CAS No. 124438 -51 -3) is a multifaceted compound with promising applications across diverse fields. Its unique structure, coupled with recent research findings, positions it as a key player in advancing chemical science and drug discovery.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)